Hahn Capital Management LLC lifted its stake in Genpact Limited (NYSE:G) by 23.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,042,970 shares of the business services provider’s stock after buying an additional 200,728 shares during the period. Genpact makes up approximately 3.1% of Hahn Capital Management LLC’s holdings, making the stock its 17th largest holding. Hahn Capital Management LLC’s holdings in Genpact were worth $33,104,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. The Manufacturers Life Insurance Company increased its holdings in shares of Genpact by 7.5% in the second quarter. The Manufacturers Life Insurance Company now owns 6,508 shares of the business services provider’s stock worth $181,000 after buying an additional 455 shares during the period. Sit Investment Associates Inc. increased its holdings in shares of Genpact by 4.5% in the fourth quarter. Sit Investment Associates Inc. now owns 37,100 shares of the business services provider’s stock worth $1,178,000 after buying an additional 1,590 shares during the period. Commerzbank Aktiengesellschaft FI increased its holdings in shares of Genpact by 12.4% in the third quarter. Commerzbank Aktiengesellschaft FI now owns 16,466 shares of the business services provider’s stock worth $473,000 after buying an additional 1,816 shares during the period. Advisor Group Inc. increased its holdings in shares of Genpact by 59.8% in the third quarter. Advisor Group Inc. now owns 5,017 shares of the business services provider’s stock worth $145,000 after buying an additional 1,878 shares during the period. Finally, State of Wisconsin Investment Board increased its holdings in shares of Genpact by 7.1% in the fourth quarter. State of Wisconsin Investment Board now owns 31,327 shares of the business services provider’s stock worth $994,000 after buying an additional 2,076 shares during the period. Hedge funds and other institutional investors own 90.99% of the company’s stock.
Shares of Genpact Limited (G) opened at $31.88 on Thursday. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 0.71. The stock has a market capitalization of $6,243.57, a PE ratio of 21.37, a P/E/G ratio of 2.08 and a beta of 0.63. Genpact Limited has a 12 month low of $23.34 and a 12 month high of $34.79.
Genpact (NYSE:G) last posted its quarterly earnings data on Monday, February 12th. The business services provider reported $0.43 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.41 by $0.02. The business had revenue of $734.41 million for the quarter, compared to analysts’ expectations of $723.55 million. Genpact had a return on equity of 22.75% and a net margin of 9.61%. The business’s revenue was up 7.7% on a year-over-year basis. During the same period in the previous year, the firm posted $0.43 EPS. analysts predict that Genpact Limited will post 1.55 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 21st. Shareholders of record on Friday, March 9th will be given a dividend of $0.075 per share. This represents a $0.30 annualized dividend and a yield of 0.94%. This is a boost from Genpact’s previous quarterly dividend of $0.06. The ex-dividend date of this dividend is Thursday, March 8th. Genpact’s payout ratio is presently 22.39%.
Several research firms recently issued reports on G. Zacks Investment Research cut Genpact from a “buy” rating to a “hold” rating in a research note on Tuesday, January 9th. Cantor Fitzgerald reissued a “buy” rating and issued a $36.00 target price on shares of Genpact in a research note on Tuesday, February 13th. BMO Capital Markets raised their target price on Genpact to $35.00 and gave the stock a “market perform” rating in a research note on Tuesday, February 13th. Citigroup cut their target price on Genpact from $39.00 to $37.50 and set a “buy” rating on the stock in a research note on Tuesday, February 13th. Finally, JPMorgan Chase & Co. cut their target price on Genpact from $38.00 to $37.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 14th. One analyst has rated the stock with a sell rating, three have issued a hold rating and eight have given a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $34.65.
In other Genpact news, Director James C. Madden sold 4,270 shares of Genpact stock in a transaction that occurred on Thursday, February 15th. The stock was sold at an average price of $30.92, for a total transaction of $132,028.40. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, SVP Arvinder Singh sold 22,855 shares of Genpact stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $32.23, for a total value of $736,616.65. Following the sale, the senior vice president now directly owns 37,623 shares in the company, valued at $1,212,589.29. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 49,815 shares of company stock worth $1,638,971. Insiders own 1.41% of the company’s stock.
Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.